Late-Clinical Stage
Filters
Sort by
- All
- ASX Listed
- Clinical Development
- Commercialisation
- Early Stage
- Exploration
- Fund
- Growth Stage
- Initial Coin Offering (ICO)
- Initial Public Offering (IPO)
- Late-Clinical Stage
- Listed
- Mature Stage
- Phase 2 Clinical Trials
- Pre-Clinical Stage
- Pre-ICO
- Pre-IPO
- Pre-Registration
- Pre-Series A
- Project Financing
- Research and Development
- Security Token Offering (STO)
- Seed Capital
- Series A
- Series B
- Series C
- SGX Listed
- Startup
Pictor Ltd
Biotechnology / Medical Devices Pictor has developed novel diagnostic tests that allow up to 9 diseases or biomarkers to be detected from one sample. Pictor has used this patented…
Telix Pharmaceuticals Limited (ASX: TLX)
Healthcare / Biotechnology / Life Sciences Telix is a late-stage radiopharmaceutical company developing a broad portfolio of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix’s products address significant unmet…
Opuz Pty Limited
Healthcare / Biotechnology / Medical Devices Opuz is a wearable monitoring ring that is a revolution in diabetes technology. In a recent clinical study Opuz demonstrated that it has the potential…
Stackr
Fintech / Big Data Stackr is a global long-term savings solution, through which a personalized trust structure allows investors to hold a diversified portfolio of both capital and digital…
NeuClone Pharmaceuticals
Healthcare / Biotechnology / Pharmaceuticals The singular focus of the team at NeuClone Pharmaceuticals is to be the lowest cost producer of many of the world’s top-selling biologic drugs as…
Pluristem Therapeutics Inc.
Biotechnology Pluristem Therapeutics is a leading developer of placenta-based cell therapy products entering several pivotal trials. Pluristem has reported robust clinical trial data in multiple indications for…
OncoSil Medical (ASX:OSL)
OncoSil Medical is now moving into an exciting and pivotal time in its commercialisation timeline for OncoSil™ – and it is pleased to report that…
Loading...